Fred Alger Management’s Maravai LifeSciences MRVI Stock Holding History

Fred Alger Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-80,254	Closed	-$1.12M	–	552
2023 Q1	$1.12M	Buy	80,254 +32	+0%	+$460	0.01%	382
2022 Q4	$1.15M	Sell	80,222 -13,904	-15%	-$219K	0.01%	373
2022 Q3	$2.4M	Buy	94,126 +1,889	+2%	+$47.4K	0.01%	323
2022 Q2	$2.62M	Buy	92,237 +10,396	+13%	+$329K	0.01%	321
2022 Q1	$2.89M	Sell	81,841 -488	-0.6%	-$16.4K	0.01%	318
2021 Q4	$3.45M	Sell	82,329 -3,020	-4%	-$122K	0.01%	325
2021 Q3	$4.19M	Buy	85,349 +1,240	+1%	+$60.5K	0.01%	299
2021 Q2	$3.51M	Sell	84,109 -1,114	-1%	-$43.2K	0.01%	322
2021 Q1	$3.04M	Sell	85,223 -1,073	-1%	-$35.5K	0.01%	322
2020 Q4	$2.42M	Buy	+86,296	New	+$2.4M	0.01%	323

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fred Alger Management's MRVI Position: Q2 2023 in Review

Fred Alger Management sold out of Maravai LifeSciences (MRVI) in Q2 2023, closing a stake of 80,254 shares — an estimated $1.12M sold.

Fred Alger Management first reported a position in MRVI in Q4 2020 and held it in 10 quarters. The position peaked at $4.19M in Q3 2021. 221 funds tracked by Wall St. Rank hold MRVI as of Q2 2023.

Fred Alger Management reported no remaining Maravai LifeSciences position as of Q2 2023 after selling out during the quarter.
Fred Alger Management sold 80,254 Maravai LifeSciences shares in Q2 2023, an estimated $1.12M.
Fred Alger Management first reported a position in Maravai LifeSciences in Q4 2020 and held it in 10 quarters.
Fred Alger Management's Maravai LifeSciences position peaked at $4.19M in Q3 2021.
221 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2023.

Based on Fred Alger Management's 13F filing for Q2 2023, filed 14 Aug 2023.